Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines
- 1 June 1982
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 36 (3) , 1102-1108
- https://doi.org/10.1128/iai.36.3.1102-1108.1982
Abstract
An enzyme-linked immunosorbent assay was used to measure isotype-specific antibody to purified hemagglutinin (HA) of influenza A virus, using serum and nasal-wash specimens from young children undergoing primary infection with live cold-adapted influenza A/Alaska/77 (H3N2) or A/Hong Kong/77 (H1N1) candidate vaccine virus. The serum antibody response followed the pattern expected for a primary viral infection. Each of 17 vaccinated children had a serum immunoglobulin G (IgG) HA antibody response, 16 had an IgM antibody response, and 13 had an IgA antibody response. Nasal-wash HA antibody was detected in the IgA, IgM, and IgG isotypes. Of the 17 vaccinated children, 14 had an IgA response, 13 had an IgM response, and 9 had an IgG response. Most of the IgA and IgM HA antibody was actively secreted locally, whereas only some of the IgG HA antibody could be shown to be actively secreted into the respiratory tract. There was a good correlation between the level of nasal-wash antibodies measured by the HA-specific IgA enzyme-linked immunosorbent assay and by a plaque neutralization assay. These data indicate that intranasal vaccination of susceptible children with live, attenuated, cold-adapted influenza A viruses efficiently stimulates both systemic and local antibody responses.This publication has 28 references indexed in Scilit:
- Protection of Infants from Infection with Influenza A Virus by Transplacentally Acquired AntibodyThe Journal of Infectious Diseases, 1980
- Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: Nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25° between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60Virology, 1979
- ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITALThe Lancet, 1979
- The Immunologic Response to Infection with Respiratory Syncytial Virus in InfantsThe Journal of Infectious Diseases, 1978
- Cold adapted variants of influenza AArchiv für die gesamte Virusforschung, 1977
- Pilot Studies on Recombinant Cold-Adapted Live Type A and B Influenza Virus VaccinesThe Journal of Infectious Diseases, 1977
- Mechanism of Mucosal Immunity to Viral Infections in A Immunoglobulin-Deficiency SyndromesExperimental Biology and Medicine, 1974
- Temperature-Sensitive Mutants of Influenza Virus. III. Further Characterization of the ts-1[E] Influenza A Recombinant (H3N2) Virus in ManThe Journal of Infectious Diseases, 1973
- Respiratory Syncytial Virus Neutralizing Activity in Nasal Secretions Following Natural InfectionExperimental Biology and Medicine, 1969
- Identification in a recombinant influenza virus of structural proteins derived from both parentsVirology, 1966